Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM‐AHF trial
暂无分享,去创建一个
G. Filippatos | M. Metra | J. Butler | F. Ruschitzka | G. Rosano | I. Macdougall | P. van der Meer | B. Kirwan | M. Pagnesi | D. Tomasoni | F. Dorigotti | S. Anker | P. Meer | V. Fabien | E. Jankowska | P. Ponikowski | Ewa Jankowska